JMACU

Maxpro Capital Acquisition (JMACU)

Maxpro Capital Acquisition Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:JMACU

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/04/10	22 : 01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/04/01	05 : 01	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/03/30	21 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/03/30	06 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/03/30	06 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/03/30	05 : 25	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/03/30	05 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/03/22	05 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/02/15	06 : 56	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/02/14	06 : 08	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/02/10	21 : 08	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/01/14	06 : 34	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/01/14	06 : 13	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/01/11	06 : 32	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/01/11	06 : 24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2023/01/11	06 : 05	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/11/15	22 : 00	GlobeNewswire Inc.	Apollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/10/15	05 : 59	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/10/15	05 : 54	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/10/08	05 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/10/08	05 : 05	GlobeNewswire Inc.	Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/09/15	19 : 22	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/09/15	01 : 04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/09/15	01 : 04	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/09/15	01 : 03	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/09/14	21 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/09/14	21 : 30	GlobeNewswire Inc.	Apollomics Inc., a Late-Stage Clinical Biopharmaceutical Company to be Listed on Nasdaq Through Business Combination with Maxpro Capital Acquisition Corp.	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/02/15	06 : 15	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2022/01/14	06 : 06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation
2021/11/26	23 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JMACU	Maxpro Capital Acquisition Corporation